HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

Market Cap	4.16B
Revenue (ttm)	10.12B
Net Income (ttm)	180.78M
Shares Out	579.89M
EPS (ttm)	0.31
PE Ratio	23.03
Forward PE	n/a
Dividend	0.14 (2.00%)
Ex-Dividend Date	n/a

Volume	3,454,000
Average Volume	8,439,301
Open	7.18
Previous Close	7.20
Day's Range	7.14 - 7.27
52-Week Range	5.09 - 11.28
Beta	0.48
RSI	39.72
Earnings Date	Apr 12, 2025

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China. The company offers Chinese and Western patent medicines, Chinese herbal medicines, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatment, scientific research, prevent...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 2,870
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600829

Financial Performance

In 2024, SHA:600829's revenue was 10.05 billion, a decrease of -3.29% compared to the previous year's 10.39 billion. Earnings were 213.27 million, a decrease of -27.00%.